Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study. [electronic resource]
Producer: 20180418Description: e501 p. digitalISSN:- 2044-5385
- Adolescent
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Blood Proteins -- analysis
- Cyclophosphamide -- therapeutic use
- Cytarabine -- administration & dosage
- Doxorubicin -- therapeutic use
- Etoposide -- therapeutic use
- Female
- Humans
- Immunophenotyping -- methods
- Lymphoma, Follicular -- blood
- Lymphoma, Large B-Cell, Diffuse -- blood
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Monitoring, Physiologic -- methods
- Prednisolone -- therapeutic use
- Prednisone -- therapeutic use
- Prognosis
- Protein Array Analysis -- methods
- Proteomics -- methods
- Risk Factors
- Rituximab
- Survival Analysis
- Vincristine -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Letter; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.